Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
Ginell Ristic Post
High Impact
Professor
Also affiliated: Cleveland Clinic (2000); University of Kentucky (2000–2013); Medical University of South Carolina (2008–2011); Inserm (2010); Utrecht University (2002); Université de Lille (2010); Institut Pasteur de Lille (2010); University of California San Diego (1995–1997); University of Chicago (1992–1993); Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires (2010); Université Lille Nord de France (2010)
Pathology, College of Medicine
21 h-index
125 pubs
1,701 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Ginell R. Post's research interests are centered on hematopathology, with a specific focus on coagulopathies associated with cancer and inflammation. Dr. Post employs molecular-genetic and immunohistochemical approaches to investigate the classification and pathobiology of hematopoietic diseases.
Dr. Post's work has contributed to understanding various hematological conditions. Publications include research on Rad52's role in DNA recombination, the identification of NEK2 as a therapeutic target in lymphoma, and the immune responses induced by a P10s-PADRE vaccine in breast cancer patients. Additional studies have explored rare presentations of intestinal T-cell lymphoma, the toxicity of drug delivery agents, and the regulation of hepatic lncRNAs. Dr. Post also investigates the relationship between Hairy Cell Leukemia and severe acute respiratory distress syndrome.
With an h-index of 21 and 1,765 citations across 128 publications, Dr. Post is recognized as a highly cited researcher. Key collaborators at the University of Arkansas for Medical Sciences include Vijay Patel, Sydnye L. Shuttleworth, Samantha Kendrick, and Syed Hassan Mehdi, with whom Dr. Post shares 39 co-authored publications. Dr. Post leads an active research group and maintains a lab website.
Research Overview
My current clinical and research interests are in the area of hematopathology with focus on cancer- and inflammation-related coagulopathies and use molecular-genetic and immunohistochemical approaches to classify and understand the pathobiology of hematopoietic diseases.
Metrics
- h-index: 21
- Publications: 125
- Citations: 1,701
Positions
-
Professor 2008–presentUniversity of Arkansas for Medical Sciences Pathology, College of Medicine Institutional directory
Selected Publications
-
Acute Myeloid Leukemia with Hemophagocytosis: Diagnostic Cues and Potential Pitfalls. (2025)PubMed OpenAlex
-
Strategies to Optimize Overutilization of Provider-Ordered Peripheral Blood Smear Review in an University Hospital Setting (2024)
-
Unexpected Presentations of Histiocytic Disorders as Mass Lesions in the Central Nervous System and Spine (2024)
Collaboration Network
Top Collaborators
Steven R. Post
University of Arkansas for Medical Sciences
12 shared publications
In database
- ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells
- Prolonged prothrombin time correlates with serum monoclonal protein concentration in patients with plasma cell dyscrasia
- Diagnostic Utility of Interleukin-6 Expression by Immunohistochemistry in Differentiating Castleman Disease Subtypes and Reactive Lymphadenopathies.
- The Ral Exchange Factor Rgl2 Promotes Cardiomyocyte Survival and Inhibits Cardiac Fibrosis
- Effect of Serum Immunoglobulins on Routine Coagulation Tests: A Comparison of Coagulation Analyzers using Mechanical and Optical Clot Detection.
Showing 5 of 12 shared publications
Daisy Alapat
University of Arkansas for Medical Sciences
6 shared publications
In database
- The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype
- Prolonged prothrombin time correlates with serum monoclonal protein concentration in patients with plasma cell dyscrasia
- A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange
- Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols
- The utility of B-cell receptor gene rearrangement studies in diagnosing diffuse large B-cell lymphoma with plasmacytic differentiation.
Showing 5 of 6 shared publications
Mark S. Smeltzer
University of Arkansas for Medical Sciences
4 shared publications
In database
- sarA ‐mediated repression of protease production plays a key role in the pathogenesis of S taphylococcus aureus USA 300 isolates
- Impact of the functional status of saeRS on in vivo phenotypes of S taphylococcus aureus sarA mutants
- Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone
- Biodistribution and toxicity assessment of photoactivatable antibody-conjugated, antibiotic loaded gold nanocages for the treatment of bacterial infections (Conference Presentation)
Zeba N. Singh
University of Arkansas for Medical Sciences (US)
4 shared publications
- Cytopenia, Dysplasia, and Monocytosis: A Precursor To Chronic Myelomonocytic Leukemia or a Distinct Subgroup? Case Reports and Review of Literature
- Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols
- Clinically Silent Massive Fetomaternal Hemorrhage: Important Lessons from an Illustrative Case
- Fulminant Onset of Acute Leukemia (FOAL) After Total Therapies (TT) for Multiple Myeloma (MM): Absence of MDS Pathological Criteria within 3 Months of Prior MM Follow-up
Frits van Rhee
University of Arkansas for Medical Sciences
4 shared publications
In database
- The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype
- Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing
- Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols
- Fulminant Onset of Acute Leukemia (FOAL) After Total Therapies (TT) for Multiple Myeloma (MM): Absence of MDS Pathological Criteria within 3 Months of Prior MM Follow-up
John Lazarchick
4 shared publications
- The utility of fluorescence in situ hybridization (FISH) analysis in diagnosing graft versus host disease following orthotopic liver transplant.
- Translocation t(3;8;9)(p25;p21;q34) in a patient with features of 8p11 myeloproliferative syndrome: A unique case and review of the literature
- Clinically Silent Massive Fetomaternal Hemorrhage: Important Lessons from an Illustrative Case
- Osseous Hodgkin Lymphoma
Soumya Pandey
University of Arkansas Medical Center
4 shared publications
In database
- Prolonged prothrombin time correlates with serum monoclonal protein concentration in patients with plasma cell dyscrasia
- Hematolymphoid Malignancies Presenting with Spinal Epidural Mass and Spinal Cord Compression: A Case Series with Rare Entities.
- Isolated Prolonged Prothrombin Time Correlates with Serum Immunoglobulin Levels in Patients with Multiple Myeloma
- Acute Myeloid Leukemia with Hemophagocytosis: Diagnostic Cues and Potential Pitfalls.
Youzhong Yuan
University of Arkansas for Medical Sciences
4 shared publications
In database
- Diagnostic Utility of Interleukin-6 Expression by Immunohistochemistry in Differentiating Castleman Disease Subtypes and Reactive Lymphadenopathies.
- Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment
- Identification of a Novel Phenotype of Myeloid Cells in Classical Hodgkin Lymphoma
- Absence of Class A Scavenger Receptor Distinguishes a Phenotype of Tumor Associated Macrophages in Classic Hodgkin's Lymphoma
Bart Barlogie
University of Arkansas for Medical Sciences
3 shared publications
In database
- The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype
- Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols
- Fulminant Onset of Acute Leukemia (FOAL) After Total Therapies (TT) for Multiple Myeloma (MM): Absence of MDS Pathological Criteria within 3 Months of Prior MM Follow-up
A. Zielińska
University of Arkansas for Medical Sciences (US)
2 shared publications
- sarA ‐mediated repression of protease production plays a key role in the pathogenesis of S taphylococcus aureus USA 300 isolates
- Impact of the functional status of saeRS on in vivo phenotypes of S taphylococcus aureus sarA mutants
Karen E. Beenken
University of Arkansas for Medical Sciences
2 shared publications
In database
- sarA ‐mediated repression of protease production plays a key role in the pathogenesis of S taphylococcus aureus USA 300 isolates
- Impact of the functional status of saeRS on in vivo phenotypes of S taphylococcus aureus sarA mutants
Lara N. Mrak
University of Arkansas for Medical Sciences (US)
2 shared publications
- sarA ‐mediated repression of protease production plays a key role in the pathogenesis of S taphylococcus aureus USA 300 isolates
- Impact of the functional status of saeRS on in vivo phenotypes of S taphylococcus aureus sarA mutants
Horace J. Spencer
University of Arkansas for Medical Sciences
2 shared publications
In database
- sarA ‐mediated repression of protease production plays a key role in the pathogenesis of S taphylococcus aureus USA 300 isolates
- Impact of the functional status of saeRS on in vivo phenotypes of S taphylococcus aureus sarA mutants
Robert A. Skinner
University of Arkansas for Medical Sciences (US)
2 shared publications
- sarA ‐mediated repression of protease production plays a key role in the pathogenesis of S taphylococcus aureus USA 300 isolates
- Impact of the functional status of saeRS on in vivo phenotypes of S taphylococcus aureus sarA mutants
Michele Cottler‐Fox
University of Arkansas for Medical Sciences
2 shared publications
In database
- A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal
- A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange
Similar Researchers
Based on overlapping research topics
Mina Khoshaba
Cancer-related molecular mechanisms research
Lymphoma Diagnosis and Treatment
Immune Response and Inflammation
Claire Doshier
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Lymphoma Diagnosis and Treatment
Immune Response and Inflammation
Amy Michael
Cancer-related molecular mechanisms research
Immune Response and Inflammation
Disease Mechanisms Research
Kennith Swafford
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Lymphoma Diagnosis and Treatment
Disease Mechanisms Research
Youzhong Yuan
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Lymphoma Diagnosis and Treatment
Disease Mechanisms Research
Lee Ann Jolly
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Immune Response and Inflammation
Disease Mechanisms Research